Article Information
PubMed
Published By
History
- Received February 20, 2019
- Revision received August 9, 2019
- Accepted August 14, 2019
- Published online August 26, 2019.
Copyright & Usage
Copyright © 2019 Vargas Abonce et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- 1Centre for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS UMR 7241/INSERM U1050, PSL Research University, Labex Memolife Paris Science et Lettres, 75005 Paris, France
- 2BrainEver, 75012 Paris, France
- Correspondence should be addressed to Alain Prochiantz at Alain.prochiantz{at}college-de-france.fr or Kenneth L. Moya at Ken.moya{at}college-de-france.fr.
Author contributions
A.P. and K.L.M. designed research; S.E.V.A. and M.L. performed research; S.E.V.A., M.L., and K.L.M. analyzed data; S.E.V.A., M.L., A.P., and K.L.M. wrote the paper.
↵* S.E.V.A. and M. L. contributed equally to this work.
Disclosures
A.P and K.L.M. are listed on several patents for the use of homeoproteins for the treatment of neurodegenerative disease, and they are cofounders and hold shares in a company developing homeoproteins for therapeutic use. The authors declare no other competing financial interests.
This research was supported by a MemoLife Labex PhD Fellowship to S.E.V.A., Association Nationale de la Recherche et de la Technologie Grant Cifre/ANRT 2017/0488 to M.L., BrainEver, and HomeoSign Grant ERC2013-AdG 339379.
Funding
MemoLife Labex PhD fellowship
Association Nationale de la Recherche et de la Technologie (ANRT)
Cifre/ANRT n{degree sign} 2017/0488BrainEver
EC | European Research Council (ERC)
HomeoSIGN ERC -2013-AdG n{degree sign}339379
Other Version
- You are viewing the most recent version of this article.
- previous version (August 26, 2019).